NYSE:PTHS | Cash Flow Statement | Pelthos Therapeutics Inc.

Complete source-backed cash-flow history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$23.42M
2026-03-31-$25.07M-$13.13M$194,000.00-$194,000.00$27.52M
2025-12-31-$21.66M-$6.25M-$8M$18.02M
2025-09-30-$16.24M
2025-06-30-$3.45M
2025-03-31-$1.97M-$632,000.00$0.00$0.00$250,000.00
2024-12-31-$1.93M-$670,000.00-$72,000.00
2024-09-30-$1.7M
2024-06-30-$1.77M
2024-03-31-$2.56M-$1.99M$5.67M
2023-12-31-$4.04M-$356,807.00$430,412.00
2023-09-30-$1.42M
2023-06-30-$953,347.00
2023-03-31-$966,561.00-$173,369.00$166,903.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$43.32M-$22.59M$99,000.00-$5.24M$0.00$45.34M
2024-12-31-$7.96M-$5.79M$0.00$0.00$75,000.00$6.21M
2023-12-31-$7.38M-$981,031.00$1.02M
2022-12-31-$2.46M-$1.57M$1.62M